Intelligent Bio Solutions (INBS) announced its participation at the All Rise Conference, RISE25, in Kissimmee, Florida from May 28 to 31, 2025. The Company will support its U.S. distribution partner SMARTOX, showcasing INBS’ Intelligent Fingerprinting Drug Testing Solution, which is already used in the U.S. in a Forensic Use Only capacity through its partnership with SMARTOX. Harry Simeonidis, President and CEO at INBS, and Doug Heath, Vice President of Global Sales at INBS, will join Duffy Nabors, Vice President of Sales and Marketing at SMARTOX, to demonstrate the Company’s portable, easy-to-use Intelligent Fingerprinting Drug Screening System. The System uses fingerprint sweat to detect recent drug use, including cannabis (THC), cocaine, methamphetamine, and opiates, and deliver results in under ten minutes. The hygienic and discreet collection method is well-suited to treatment court settings, probation programs, and other criminal justice applications where privacy, reliability, and speed are critical.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio announces completion of high-volume workforce drug test
- Intelligent Bio Solutions Expands Global Operations
- Intelligent Bio accelerates global adoption of fingerprint drug testing
- Intelligent Bio Solutions Reports Strong Q3 2025 Results
- Intelligent Bio Solutions reports Q3 EPS (44c) vs ($1.43) last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue